French Carrson, Jackson Jace, Monahan Zach, Murray Kelly, Hartwell Micah
Office of Medical Student Research, Oklahoma State University College of Osteopathic Medicine at Cherokee Nation, 19500 E Ross St., Tahlequah, OK, 74464, USA.
Department of Emergency Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
Intern Emerg Med. 2025 Mar 31. doi: 10.1007/s11739-025-03923-5.
Despite efforts to mitigate high opioid prescription frequencies, previous research showed minimal change within emergency departments (ED) in the United States, and a few studies investigate prescription provider types. Thus, our primary objective was to assess opioid prescribing rates by differing healthcare team members using data from the National Hospital Ambulatory Medical Care Survey (NHAMCS). Using the 2019-2021 NHAMCS, we calculated the overall opioid prescription rate during ED visits by provider type. Next, we estimated opioid prescription rates by provider type annually and determined differences by year using design-based X tests and regression models. From 2019 through 2021, 7428 of 50,548 visits involved opioids, representing 15.62% of all ED visits. During this timeframe, 16.59% of total encounters with opioid prescriptions were among attending/consulting physicians. This was followed by physician assistants (13.91%), nurse practitioners (10.67%), and residents (7.28%). Compared to 2019, opioid prescribing rates showed no significant changes; however, resident physicians showed a significant decrease, and RNs showed a significant increase. From our analysis, opioid prescribing rates in the ED were highest among attending/consulting physicians, and rates among physician assistants and nurse practitioners were higher than 10%. Resident physicians had a significant decrease in opioid prescriptions, while RNs had an increase-likely due to new laws enacted during this timeframe. Removing barriers to alternative pain management for acute and long-term care may lessen rates of opioid prescriptions-including patient and provider training, physical therapists inclusion, and osteopathic manipulative therapy incorporation.
尽管人们努力降低阿片类药物的高处方频率,但先前的研究表明,美国急诊科的情况变化甚微,而且很少有研究调查处方提供者的类型。因此,我们的主要目标是利用国家医院门诊医疗调查(NHAMCS)的数据,评估不同医护团队成员的阿片类药物处方率。我们使用2019 - 2021年的NHAMCS,按提供者类型计算了急诊科就诊期间的总体阿片类药物处方率。接下来,我们每年按提供者类型估计阿片类药物处方率,并使用基于设计的X检验和回归模型确定各年份之间的差异。从2019年到2021年,50548次就诊中有7428次涉及阿片类药物,占所有急诊科就诊的15.62%。在此期间,开具阿片类药物处方的总人次中,16.59%是主治/会诊医生。其次是医师助理(13.91%)、执业护士(10.67%)和住院医师(7.28%)。与2019年相比,阿片类药物处方率没有显著变化;然而,住院医师的处方率显著下降,注册护士的处方率显著上升。从我们的分析来看,急诊科中主治/会诊医生的阿片类药物处方率最高,医师助理和执业护士的处方率高于10%。住院医师的阿片类药物处方显著减少,而注册护士的处方增加——这可能是由于在此期间颁布了新法律。消除急性和长期护理中替代疼痛管理的障碍可能会降低阿片类药物的处方率,包括患者和提供者培训、纳入物理治疗师以及采用整骨手法治疗。